Get startedLog in
    Picture of Cerevel Therapeutics Holdings logo

    CERE — Cerevel Therapeutics Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    AbbVie to buy drug developer Cerevel for $8.7 billion

    Picture of Cerevel Therapeutics Holdings logoCerevel Therapeutics Holdings
    06/12/2023 21:34
    Dec 6 (Reuters) - AbbVie  ABBV.N  said on Wednesday it
would acquire Cerevel Therapeutics  CERE.O  for a total equity
value of about $8.7 billion.

 (Reporting by Ananya Mariam Rajesh in Bengaluru; Editing by
Maju Samuel)
 ((AnanyaMariam.Rajesh@thomsonreuters.com ; Twitter: https://twitter.com/AnanyaMariam;))

    Recent news on Cerevel Therapeutics Holdings

    See all news